IFITM3 and Alzheimer disease: We also identified the upregulation of IFITM3 (Fig. 6A), a protein elevated in the brain tissue of a subset of late-onset AD patients, which is associated with increased neuroinflammation and correlated with enhanced γ-secretase activity and amyloid beta production [79].